Searchable abstracts of presentations at key conferences in endocrinology

ea0016p18 | Adrenal | ECE2008

Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency

Zeina Chakhtoura , Anne Bachelot , Dinane Samara-Boustani , Jean-Charles Ruiz , Bruno Donadille , Jerome Dulon , Sophie Christin-Maitre , Claire Bouvattier , Marie-Charles Raux-Demay , Philippe Bouchard , Jean-Claude Carel , Juliane Leger , Frederique Kuttenn , Michel Polak , Philippe Touraine

Introduction: There are contradictory results concerning bone mineral density status in adult patients with congenital adrenal hyperplasia. To resolve this issue, we hypothesized that there could be a correlation between BMD and a total cumulative glucocorticoid dose from the diagnosis in early infancy to adulthood. We then conducted a retrospective in a referral centers for CAH. Thirty-eight adult patients (28 women, 10 men, aged 16–39 years) suffering from CAH and treat...

ea0070aep12 | Adrenal and Cardiovascular Endocrinology | ECE2020

Identification of clinical parameters predictive of ARMC5 mutation in a large cohort of primary bilateral macronodular adrenal hyperplasia (PBMAH) patients.

Bouys Lucas , Vaczlavik Anna , Vaduva Patricia , Espiard Stéphanie , Assié Guillaume , Libe Rossella , Perlemoine Karine , Ragazzon Bruno , Guignat Laurence , groussin Lionel , Olivier Chabre , Sophie Christin-Maitre , Hervé Lefebvre , Raffin-Sanson Marie-Laure , Vantyghem Marie-Christine , Cole Trevor , Beuschlein Felix , Quinkler Marcus , Angelousi Anna , brue Thierry , Sadoul Jean-Louis , Agapito Ana , Tabarin Antoine , Borson-Chazot Francoise , Kroiss Matthias , Arlt Wiebke , Chanson Philippe , Reincke Martin , North Marie-Odile , Bertherat Jerome

Introduction: PBMAH is a rare but heterogeneous disease, characterized by multiple benign adrenal macronodules with variable levels of cortisol excess. In 2013, our team discovered germline heterozygous inactivating mutations of ARMC5, acting as a tumor suppressor gene. ARMC5 mutation rate is 50% in patients with PBMAH treated by adrenalectomy for severe hypercortisolism, 80% in familial cases and 20% in sporadic cases according to the current literature. The...